Jeremy R Duvall

3PUBLICATIONS
41CO-AUTHORS
Biologically active moleculesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 03, 2025
XMT-2056, a HER2-Directed STING Agonist Antibody-Drug Conjugate, Induces Innate Antitumor Immune Responses by Acting on Cancer Cells and Tumor-Resident Immune Cells.

Raghida A Bukhalid, Jeremy R Duvall, Kelly Lancaster

|Jul 24, 2023
Discovery and Optimization of a STING Agonist Platform for Application in Antibody Drug Conjugates.

Jeremy R Duvall, Joshua D Thomas, Raghida A Bukhalid

|Jun 09, 2023
Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody-Drug Conjugate for the Treatment of Cancer.

Dorin Toader, Shawn P Fessler, Scott D Collins

Pageof 1

Frequent Collaborators

3 joint publications

Kalli C Catcott

2 joint publications

Dorin Toader

2 joint publications

Timothy B Lowinger

2 joint publications

Scott D Collins